Skip to main content
. 2021 Jun 16;10(6):1512. doi: 10.3390/cells10061512

Table 1.

Differential expression of different parameters among the study groups, in addition to patients with unstable angina versus STEMI.

i Median F p
miRNA-221-3p unstable angina 21 0.2300 a 13.053 a 0.000
STEMI 31 0.1500 b 0.00
NSTEMI 16 0.1300 c 0.874
non cardiac chest pain 21 7.5000
healthy control 21 16.4000
miRNA 197-5p unstable angina 21 4.0395 a 7.473 a 0.000
STEMI 31 14.6000 b 0.001
NSTEMI 16 10.4500 c 0.001
non cardiac chest pain 21 1.0000
healthy control 21 0.3000
ABHD4 mRNA unstable angina 21 8.80000 a 9.142 a 0.000
STEMI 31 7.80000 b 0.01
NSTEMI 16 21.40000 c 0.103
non cardiac chest pain 21 0.04000
healthy control 21 0.01000
FENDRR lncRNA unstable angina 21 1.30000 a 8.994 a 0.000
STEMI 31 0.06000 b 0.00
NSTEMI 16 0.17000 c 0.968
non cardiac chest pain 21 6.65000
healthy control 21 16.50000
Creatine kinase-MB (CK-MB) unstable angina 21 17.00 a 10.947 a 0.000
STEMI 31 44.00 b 0.128
NSTEMI 16 29.50 c 0.1
non cardiac chest pain 21 33.00
healthy control 21 8.00
Cardiac Troponin unstable angina 21 17.00 a 79.243 a 0.000
STEMI 31 44.00 b 0.154
NSTEMI 16 29.50 c 0.1
non cardiac chest pain 21 33.00
healthy control 21 8.00

a Statistics among all groups, b Statistics UA versus healthy control, c UNA versus STEMI, p-value > 0.05 is considered statistically non-significant, and p-value < 0.05 is considered statistically significant. F: One Way Anova. STEMI: ST segment elevation in myocardial infarction.